Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/58193| Title: | Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial (Nature Medicine, (2026), 32, 3, (1052-1060), 10.1038/s41591-025-04179-4). | Authors: | Nicholls S.J. ;Nelson A.J.;Ditmarsch M.;Kastelein J.J.P.;Ballantyne C.M.;Ray K.K.;Navar A.M.;Nissen S.E.;Goldberg A.C.;Brunham L.R.;Wuerdeman E.;Neild A.L.;Kling D.;Hsieh A.;Butters J.;Ference B.A.;Laufs U.;Banach M.;Mehran R.;Catapano A.L.;Szarek M.;Balinskaite V.;Davidson M.H. | Monash Health Department(s): | Monash University - School of Clinical Sciences at Monash Health | Institution: | (Nicholls, Nelson, Butters) Victorian Heart Institute, Monash University, Clayton, VIC, Australia (Ditmarsch, Kastelein, Wuerdeman, Neild, Kling, Hsieh, Davidson) NewAmsterdam Pharma, Amsterdam, Netherlands (Kastelein) Department of Vascular Medicine, University of Amsterdam, Amsterdam, Netherlands (Ballantyne) Baylor College of Medicine, Houston, TX, United States (Ray) Imperial College London, London, United Kingdom (Navar) UT Southwestern, Dallas, TX, United States (Nissen) Cleveland Clinic, Cleveland, OH, United States (Goldberg) Washington University School of Medicine, St Louis, MO, United States (Brunham) Department of Medicine and Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada (Ference) Centre for Naturally Randomized Trials, University of Cambridge, Cambridge, United Kingdom (Laufs) Klinik und Poliklinik fur Kardiologie, Leipzig University, Leipzig, Germany (Banach) Medical University of Lodz, Lodz, Poland (Banach) The John Paul II Catholic University of Lublin, Lublin, Poland (Mehran) Mt Sinai School of Medicine, New York, NY, United States (Catapano) University of Milan and Multimedica IRCCS, Milan, Italy (Szarek) University of Colorado Anschutz Medical Campus, Aurora, CO, United States (Szarek) State University of New York Downstate School of Public Health, Brooklyn, NY, United States (Balinskaite) Medpace, Cincinnati, OH, United States |
Issue Date: | 22-Apr-2026 | Copyright year: | 2026 | Publisher: | Nature Research | Place of publication: | United States | Publication information: | Nature Medicine. (no pagination), 2026. Date of Publication: 2026. | Journal: | Nature Medicine | Abstract: | Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-025-04179-4, published online 27 February 2026. In the version of this article initially published, there were typographical errors in the first paragraph of the "Effects of obicetrapib on other lipid and inflammatory parameters" section, where in the text now reading "...at day 180 of -7.9% (95% CI -17.9% to 2.0%) and at day 365 of -5.1% (95% CI -17.7% to 7.5%)," "2.0%" and "7.5%" appeared originally as "-2.0%" and "-7.5%", respectively. The text has been amended in the HTML and PDF versions of the article.Copyright © The Author(s), under exclusive licence to Springer Nature America, Inc. 2026. | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1038/s41591-026-04405-7 | PubMed URL: | 41998344 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/58193 | Type: | Article In Press | Subjects: | erratum |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.